Medical College of Georgia
Department of Medicine
I am an early-career investigator with a strong foundation in retinal neurovascular diseases, including diabetic retinopathy, retinopathy of prematurity, and ocular hypertension. My research program focuses on identifying common mechanisms of neurovascular injury across ischemic retinopathies, including neovascularization, blood-retina barrier breakdown, vascular senescence and neurodegeneration. These pathological processes drive vision loss and represent key targets for therapeutic intervention.
Although my current role as Assistant Research Scientist does not require teaching (0 FTE), I have actively participated in teaching various courses at the medical school level. My focus is on enhancing students' understanding and practical application of the subject matter. Recently, I participated in teaching MEDI 6300 Career Paths in Medicine (Spring 2025 and Fall 2025). In this course, I served as a component organizer for Ophthalmology (1 day) and as an instructor for Translational Vision Research (1 hour). Additionally, I participated in 2025 Student Educational Enrichment Program (SEEP) in the summer of 2025, where I instructed high school students in Biotechnology Techniques I (4 hours) and Biotechnology Techniques II (2 hours). I am actively participating in undergraduate research initiatives through the AU Center for Undergraduate Research and Scholarship (CURS). I am currently serving as thesis advisor to Ms. Rinu Sabu, BS in Biology (Honors) program at the College of Science and Mathematics.
I have developed substantial experience working with mouse models of oxygen-induced retinopathy (OIR) and type 1 diabetic retinopathy (DR), including in vivo assessments of retinal structure and function. As a co-investigator on a NEI-funded multi-PI R01 with Drs. Ruth Caldwell and Modesto Rojas, my current work explores the role of cholesterol homeostasis in DR and ROP, further strengthening my expertise in retinal metabolism, inflammation, and neurovascular injury. My other projects seeks to define the role of ornithine decarboxylase (ODC) in the pathogenesis of ROP and DR through the support of Knights Templar Eye Foundation Inc (KTEF) Career Starter grant (2023-2024), and Augusta University Intramural Grant Program (2024-2026).